Frankfurt - Delayed Quote EUR
Viking Therapeutics, Inc. (1VT.F)
22.01
+0.18
+(0.85%)
As of 8:06:17 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 15 | 14 |
| Avg. Estimate | -- | -- | 1.67M | 7.37M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 25M | 93.18M |
| Year Ago Sales | -- | -- | -- | 1.67M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 342.20% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1VT.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/24/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/17/2025 |
| Initiated | Goldman Sachs: Neutral | 4/8/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Initiated | Scotiabank: Sector Outperform | 2/13/2025 |
Related Tickers
PI3.DU Gubra AS
46.80
-2.94%
LYTIX.OL Lytix Biopharma AS
5.18
-3.72%
ASMB Assembly Biosciences, Inc.
10.49
+0.77%
SPRB Spruce Biosciences, Inc.
0.1378
+3.82%
PTCT PTC Therapeutics, Inc.
50.13
+0.36%
LCTX Lineage Cell Therapeutics, Inc.
0.4714
-0.13%
VNDA Vanda Pharmaceuticals Inc.
4.3600
+0.69%
GRCE Grace Therapeutics, Inc.
2.2983
+0.36%
CANF Can-Fite BioPharma Ltd.
1.1847
+0.40%
TSHA Taysha Gene Therapies, Inc.
1.8700
+2.75%